Bronchiolitis Obliterans Syndrome (BOS) Recruiting Phase 3 Trials for Fluticasone propionate (DB00588)

Also known as: Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Recruiting3 IdentifierTitlePurposeDrugs
NCT04655508Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre TransplantationTreatment